InsiderLens

03 févr. 2015CONVERSIONENTELLUS MEDICAL INC98 302—

indirect· By Fund VIII-B

03 févr. 2015PURCHASEENTELLUS MEDICAL INC23 06117.00 USD

indirect· By Fund VIII-A

03 févr. 2015CONVERSIONENTELLUS MEDICAL INC226 095—

indirect· By Fund VIII-A

03 févr. 2015PURCHASEENTELLUS MEDICAL INC319 85317.00 USD

indirect· By Fund VIII

03 févr. 2015CONVERSIONENTELLUS MEDICAL INC3 135 858—

indirect· By Fund VIII

03 févr. 2015PURCHASEENTELLUS MEDICAL INC10 02717.00 USD

indirect· By Fund VIII-B

03 févr. 2015CONVERSIONENTELLUS MEDICAL INC8 325 325—

indirect· By Fund VIIIderiv

03 févr. 2015CONVERSIONENTELLUS MEDICAL INC600 259—

indirect· By Fund VIII-Aderiv

03 févr. 2015CONVERSIONENTELLUS MEDICAL INC132 228—

indirect· By Fund VIII-Bderiv

03 févr. 2015CONVERSIONENTELLUS MEDICAL INC4 218 108—

indirect· By Fund VIIIderiv

03 févr. 2015CONVERSIONENTELLUS MEDICAL INC304 126—

indirect· By Fund VIII-Aderiv

03 févr. 2015CONVERSIONENTELLUS MEDICAL INC260 982—

indirect· By Fund VIII-Bderiv

08 avr. 2014OTHERRevance Therapeutics, Inc.8 0000.00 USD

indirect· By affiliatederiv

11 févr. 2014CONVERSIONRevance Therapeutics, Inc.200 538—

indirect· by Essex Woodlands Health Ventures Fund VIII-A, L.P.

11 févr. 2014CONVERSIONRevance Therapeutics, Inc.2 781 396—

indirect· by Essex Woodlands Health Ventures Fund VIII, L.P.

11 févr. 2014CONVERSIONRevance Therapeutics, Inc.596 812—

indirect· by Essex Woodlands Health Ventures Fund VIII, L.P.

11 févr. 2014EXERCISERevance Therapeutics, Inc.369 124—

indirect· by Essex Woodlands Health Ventures Fund VIII, L.P.

11 févr. 2014EXERCISERevance Therapeutics, Inc.11 560—

indirect· by Essex Woodlands Health Ventures Fund VIII-B, L.P.

11 févr. 2014CONVERSIONRevance Therapeutics, Inc.43 029—

indirect· by Essex Woodlands Health Ventures Fund VIII-A, L.P.

11 févr. 2014EXERCISERevance Therapeutics, Inc.26 605—

indirect· by Essex Woodlands Health Ventures Fund VIII-A, L.P.

11 févr. 2014CONVERSIONRevance Therapeutics, Inc.87 190—

indirect· by Essex Woodlands Health Ventures Fund VIII-B, L.P.

11 févr. 2014CONVERSIONRevance Therapeutics, Inc.18 708—

indirect· by Essex Woodlands Health Ventures Fund VIII-B, L.P.

11 févr. 2014EXERCISERevance Therapeutics, Inc.11 560—

indirect· by Essex Woodlands Health Ventures Fund VIII-B, L.P.deriv

11 févr. 2014CONVERSIONRevance Therapeutics, Inc.18 708—

indirect· by Essex Woodlands Health Ventures Fund VIII-B, L.P.deriv

11 févr. 2014CONVERSIONRevance Therapeutics, Inc.12 668—

indirect· by Essex Woodlands Health Ventures Fund VIII-B, L.P.deriv

ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP.

ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP.